Supplementary Table S6 from HBV Reactivation in Patients with Hepatocellular Carcinoma Treated with PD-1/-L1 Antibodies and Concurrent Antiviral Prophylaxis Agents: A Prospective Observational Study
Abstract
Supplementary Table 6. Tumor response in patients received ICIs monotherapy or combination therapy
Fields of Study & Subjects
Hepatitis B Virus Studies
Cancer Immunotherapy and Biomarkers
Hepatocellular Carcinoma Treatment and Prognosis
Publication details
- Publication date
- 17 February 2026
- Language
- EN